203 related articles for article (PubMed ID: 11975978)
1. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm.
Duquesnoy RJ
Hum Immunol; 2002 May; 63(5):339-52. PubMed ID: 11975978
[TBL] [Abstract][Full Text] [Related]
2. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.
Duquesnoy RJ; Marrari M
Hum Immunol; 2002 May; 63(5):353-63. PubMed ID: 11975979
[TBL] [Abstract][Full Text] [Related]
3. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
Duquesnoy RJ; Takemoto S; de Lange P; Doxiadis II; Schreuder GM; Persijn GG; Claas FH
Transplantation; 2003 Mar; 75(6):884-9. PubMed ID: 12660519
[TBL] [Abstract][Full Text] [Related]
4. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
Duquesnoy RJ; Howe J; Takemoto S
Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
[TBL] [Abstract][Full Text] [Related]
5. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
[TBL] [Abstract][Full Text] [Related]
6. The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients.
Lobashevsky AL; Senkbeil RW; Shoaf JL; Stephenson AK; Skelton SB; Burke RM; Deierhoi MH; Thomas JM
Hum Immunol; 2002 May; 63(5):364-74. PubMed ID: 11975980
[TBL] [Abstract][Full Text] [Related]
7. HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients.
Nambiar A; Duquesnoy RJ; Adams S; Zhao Y; Oblitas J; Leitman S; Stroncek D; Marincola F
Blood; 2006 Feb; 107(4):1680-7. PubMed ID: 16269623
[TBL] [Abstract][Full Text] [Related]
8. Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation.
Laux G; Mytilineos J; Opelz G
Transplantation; 2004 Mar; 77(6):902-7. PubMed ID: 15077035
[TBL] [Abstract][Full Text] [Related]
9. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation.
Duquesnoy RJ
Curr Opin Immunol; 2008 Oct; 20(5):594-601. PubMed ID: 18655832
[TBL] [Abstract][Full Text] [Related]
11. HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies.
Duquesnoy RJ; Marrari M
Curr Opin Organ Transplant; 2009 Aug; 14(4):403-9. PubMed ID: 19417654
[TBL] [Abstract][Full Text] [Related]
12. A structurally based approach to determine HLA compatibility at the humoral immune level.
Duquesnoy RJ
Hum Immunol; 2006 Nov; 67(11):847-62. PubMed ID: 17145365
[TBL] [Abstract][Full Text] [Related]
13. Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker.
Kosmoliaptsis V; Bradley JA; Sharples LD; Chaudhry A; Key T; Goodman RS; Taylor CJ
Transplantation; 2008 Jun; 85(12):1817-25. PubMed ID: 18580476
[TBL] [Abstract][Full Text] [Related]
14. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
Duquesnoy RJ; Marrari M
Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
[TBL] [Abstract][Full Text] [Related]
15. Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support?
Duquesnoy RJ
Transfusion; 2008 Feb; 48(2):221-7. PubMed ID: 18005328
[TBL] [Abstract][Full Text] [Related]
16. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.
Duquesnoy RJ; Askar M
Hum Immunol; 2007 Jan; 68(1):12-25. PubMed ID: 17207708
[TBL] [Abstract][Full Text] [Related]
17. Differential immunogenicity of HLA mismatches in clinical transplantation.
Claas FH; Dankers MK; Oudshoorn M; van Rood JJ; Mulder A; Roelen DL; Duquesnoy RJ; Doxiadis II
Transpl Immunol; 2005 Aug; 14(3-4):187-91. PubMed ID: 15982562
[TBL] [Abstract][Full Text] [Related]
18. HLA matching at the epitope level: the way to go.
Duquesnoy RJ
Clin Transpl; 2013; ():441-51. PubMed ID: 25095540
[TBL] [Abstract][Full Text] [Related]
19. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.
Petersdorf EW; Hansen JA; Martin PJ; Woolfrey A; Malkki M; Gooley T; Storer B; Mickelson E; Smith A; Anasetti C
N Engl J Med; 2001 Dec; 345(25):1794-800. PubMed ID: 11752355
[TBL] [Abstract][Full Text] [Related]
20. Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms.
Kosmoliaptsis V; Chaudhry AN; Sharples LD; Halsall DJ; Dafforn TR; Bradley JA; Taylor CJ
Transplantation; 2009 Sep; 88(6):791-8. PubMed ID: 19920778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
